Immunological methods for diagnosing neurocysticercosis
US4740456A · kind A · utility
6Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 1985 |
| Grant date | Apr 26, 1988 |
| Priority date | — |
| Expiry date | Aug 15, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/855
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Immunological methods are disclosed for diagnosing active human neurocysticercosis, including a serum test and a cerebrospinal fluid test. The serum test involves detecting an antibody in serum which recognizes at least one of three particular antigens isolated from Taenia solium larvae. The cerebrospinal fluid test involves detecting an antigen or antigens of larval origin, preferably by an ELISA technique.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.